Chemotherapy-induced leg ulcers: a case series
Prescribers should be made aware of skin side-effects of chemotherapies and the risk-benefit of discontinuing chemotherapy for ulcer healing should be raised. Closer monitoring to control identified cofactors of LUs is required in patients receiving this type of chemotherapy, especially if they have LU-predisposing factors.
Authors
- E. Mahé (ORCID: https://orcid.org/0000-0001-5780-1827)
- Patricia Senet (ORCID: https://orcid.org/0000-0002-9253-8419)
- A. Le Guern (ORCID: https://orcid.org/0000-0001-8753-0618)
- A. Schoeffler
- Sandra Moawad (ORCID: https://orcid.org/0000-0003-3698-4331)
- B. Villemur
- E. Goujon (ORCID: https://orcid.org/0000-0002-5522-1359)
- N. Baudot
- M. Rousselot
- Philippe Rousselot
- Michèle‐Léa Sigal
- Jean-François Cuny
- Catherine Lok
- Emilie Tella
Institutions
- Centre Hospitalier Universitaire de Grenoble (FR)
- Sorbonne Université (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Centre Hospitalier Régional de Metz-Thionville (FR)
- Centre Hospitalier Victor Dupouy (FR)
- Hôpital Saint-Louis (FR)
- Centre Hospitalier de Versailles (FR)
- Hôpital Saint-Vincent-de-Paul (FR)
- Hôpital Tenon (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Journal of Wound Care
- Published
- 2025-03-02
- DOI
- https://doi.org/10.12968/jowc.2020.0128
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63